Phase I an pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks

S (Suresh) Senan; R Rampling; MA Graham; P Wilson; H Robin; N Eckardt; N Lawson; A Mc Donald; R von Roemeling; P Workman; SB Kaye

Phase I an pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks

S (Suresh) Senan, R Rampling, MA Graham, P Wilson, H Robin, N Eckardt, N Lawson, A Mc Donald, R von Roemeling, P Workman, SB Kaye

Research output: Contribution to journal › Article › Academic › peer-review

38 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	31-38
Number of pages	8
Journal	Clinical Cancer Research
Volume	3
Publication status	Published - 1997
Externally published	Yes

Research programs

EMC 04-02-DD-04-01

Cite this

@article{e004bd3dd1aa4e8d880edc247590aa2b,

title = "Phase I an pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks",

author = "Senan, {S (Suresh)} and R Rampling and MA Graham and P Wilson and H Robin and N Eckardt and N Lawson and {Mc Donald}, A and {von Roemeling}, R and P Workman and SB Kaye",

year = "1997",

language = "Undefined/Unknown",

volume = "3",

pages = "31--38",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Phase I an pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks

AU - Senan, S (Suresh)

AU - Rampling, R

AU - Graham, MA

AU - Wilson, P

AU - Robin, H

AU - Eckardt, N

AU - Lawson, N

AU - Mc Donald, A

AU - von Roemeling, R

AU - Workman, P

AU - Kaye, SB

PY - 1997

Y1 - 1997

M3 - Article

SN - 1078-0432

VL - 3

SP - 31

EP - 38

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -